Rapid and highly sensitive HPLC and TLC methods for quantitation of amlodipine besilate and valsartan in bulk powder and in pharmaceutical dosage forms and in human plasma

Analytical Letters

Volumn 43, Issue 4, 2010, Pages 570-581

  Ramadan, Nesrin K ^a   Mohamed, Heba M ^a   Moustafa, Azza A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Amlodipine besilate; HPLC; TLC; Valsartan

Indexed keywords

EID: 76449115434     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710903406953     Document Type: Article

References (18)

1. Basavaiah, K., U. Chandrashekar, and H. C. Prameda. 2003. Sensitive spectrophotometric determination of amlodipine and felodipine using iron (III) and ferricyanide. IL Farmaco 58: 141-148.
2. Bhatt, J., S. Singh, G. Shah, S. Kambli, and S. Ameta. 2007. A rapid and sensitive LC-MS/MS method for estimation of amlodipine in human plasma. J. Biomed. Chromatogr. 21: 169-175.
3. British Pharmacopoeia. 2004. London: Her Majesty's Stationary Office.
4. Dinc, E., B. Uslu, and S. A. Ozkan. 2004. Spectral resolution of a binary mixture containing valsartan and hydrochlorothiazide by ratio spectra derivative. Anal. Lett. 37: 679-693.
5. Erk, N. 2002. Spectrophotometric analysis of valsaartan and hydrochlorothiazide. Anal. Lett. 35: 238.
6. Ferreiros, N., G. Iriarte, R. M. Alonso, and E. Ortiz. 2008. Separation and quantitation of several angiotensin II receptor antagonists in human urine by SPE-HPLC-DAD method. J. of Sep. Sci. 31: 667-676.
7. Gaetano, R., A. Garofalo, and C. Vetuschi. 2002. Photodegradation monitoring of amlodipine by derivative spectrophotometry. J. Pharm. Biomed. Anal. 27: 19-24.
8. Garrisor, J. C., Goodman, and A. G. Gillman. 2001. The Pharmacological Basis of Therapeutics. Dallas, Texas: McGraw-Hill.
9. Ivanovic, D., A. Malenovic, B. Janaic, and M. Medenica. 2007. Monitoring of the impurity level of valsartan and hydrochlorothiazide employing RP-HPLC. J. of Liq. Chromatogr. 30: 2879-2890.
10. Kocyigit, B., S. Unsalan, and S. Rollas. 2006. Determination and validation of valsartan in human plasma by HPLC. Die Pharmazie. 61: 586-589.
11. Li, C. P., X. P. Yan, and W. G. Shan. 2006. HPLC determination of amlodipine besylate tablets. Yaowu Fenxi Zazhi 26: 1878-1879.
12. Ma, Y. Y., F. Qin, X. H. Sun, and F. M. Li. 2007. Determination and pharmacokinetic study of amlodipine in human plasma by ultra performance LC. J. Pharm. Biomed. Anal. 43: 1540-1545.
13. Malesuik, M. D., S. G. Cardoso, and A. Lanzanova. 2006. Determination of amlodipine in pharmaceutical dosage forms by LC and UV spectrophotometry. J. AOAC. 89: 359-364.
14. Martindale, and S. C. Sweerman. 2004. The complete drug reference. London, UK: The Pharmaceutical Press.
15. Nafisur, R., and N. H. Syed. 2001. Spectrophotometric method for the determination of amlodipine with ninhydrin in drug formulations. IL Farmaco. 56: 731-735.
16. Nafisur, R., and N. Hoda. 2004. Application of oxidants to the spectrophotometric determination of amlodipine in pharmaceutical formulations. IL Farmaco 59: 913-919.
17. Santana, E., S. Altinay, N.G. Goger, and Z. Senturk. 2001. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first derivative spectrophotometry and LC. J. Pharm. Biomed. Anal. 25: 1009-1013.
18. The International Conference on Harmonization (ICH). 1996. Validation of Analytical Procedure (Q2B), Food and Drug Administration. USA: Government Printing Office.